BE2015C033I2 - - Google Patents

Download PDF

Info

Publication number
BE2015C033I2
BE2015C033I2 BE2015C033C BE2015C033C BE2015C033I2 BE 2015C033 I2 BE2015C033 I2 BE 2015C033I2 BE 2015C033 C BE2015C033 C BE 2015C033C BE 2015C033 C BE2015C033 C BE 2015C033C BE 2015C033 I2 BE2015C033 I2 BE 2015C033I2
Authority
BE
Belgium
Application number
BE2015C033C
Other languages
French (fr)
Original Assignee
Hormos Medical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34837941&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BE2015C033(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hormos Medical Ltd filed Critical Hormos Medical Ltd
Publication of BE2015C033I2 publication Critical patent/BE2015C033I2/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Rheumatology (AREA)
  • Reproductive Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physiology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
BE2015C033C 2004-02-13 2015-06-10 BE2015C033I2 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/777,211 US8236861B2 (en) 2004-02-13 2004-02-13 Method for enhancing the bioavailablity of ospemifene

Publications (1)

Publication Number Publication Date
BE2015C033I2 true BE2015C033I2 (zh) 2024-08-08

Family

ID=34837941

Family Applications (1)

Application Number Title Priority Date Filing Date
BE2015C033C BE2015C033I2 (zh) 2004-02-13 2015-06-10

Country Status (22)

Country Link
US (5) US8236861B2 (zh)
EP (1) EP1713458B1 (zh)
JP (2) JP5577011B2 (zh)
CN (1) CN1925847A (zh)
AT (1) ATE387910T1 (zh)
AU (1) AU2005211958B2 (zh)
BE (1) BE2015C033I2 (zh)
BR (1) BRPI0507661A (zh)
CA (1) CA2556089C (zh)
CY (2) CY1111014T1 (zh)
DE (1) DE602005005165T2 (zh)
DK (1) DK1713458T5 (zh)
ES (1) ES2302177T3 (zh)
HU (1) HUS1500030I1 (zh)
LT (1) LTC1713458I2 (zh)
LU (1) LU92736I2 (zh)
MX (1) MXPA06009274A (zh)
NO (2) NO337656B1 (zh)
PL (1) PL1713458T3 (zh)
PT (1) PT1713458E (zh)
RU (1) RU2385716C2 (zh)
WO (1) WO2005077350A1 (zh)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8236861B2 (en) 2004-02-13 2012-08-07 Hormos Medical Corporation Method for enhancing the bioavailablity of ospemifene
US8642079B2 (en) * 2004-02-23 2014-02-04 Hormos Medical Corporation Solid formulations of ospemifene
US8758821B2 (en) * 2004-05-04 2014-06-24 Hormos Medical Ltd. Oral formulations of ospemifene
PT2275098E (pt) 2004-05-04 2012-08-29 Hormos Medical Ltd Novas formulações orais de ospemifeno
RU2008122993A (ru) * 2005-11-09 2009-12-20 Хормос Медикал Лтд. (Fi) Препаративные формы фиспемифена
US8637706B2 (en) 2005-11-28 2014-01-28 Gtx, Inc. Nuclear receptor binding agents
US9409856B2 (en) 2005-11-28 2016-08-09 Gtx, Inc. Estrogen receptor ligands and methods of use thereof
US8158828B2 (en) * 2005-11-28 2012-04-17 Gtx, Inc. Nuclear receptor binding agents
US8546451B2 (en) 2005-11-28 2013-10-01 Gtx, Inc. Estrogen receptor ligands and methods of use thereof
EA018066B1 (ru) * 2005-11-28 2013-05-30 Джи Ти Икс, ИНК. Агент, связывающийся с ядерными рецепторами
EP2821385B1 (en) * 2007-02-14 2016-07-27 Hormos Medical Ltd. Method for the preparation of therapeutically valuable triphenylbutene derivatives
US7504530B2 (en) * 2007-02-14 2009-03-17 Hormos Medical Ltd. Methods for the preparation of fispemifene from ospemifene
US9427418B2 (en) 2009-02-23 2016-08-30 Gtx, Inc. Estrogen receptor ligands and methods of use thereof
US9624161B2 (en) 2009-02-23 2017-04-18 Gtx, Inc. Estrogen receptor ligands and methods of use thereof
JP6174156B2 (ja) 2012-10-19 2017-08-02 フェルミオン オサケ ユキチュア オスペミフェンの製造方法
CN103739456A (zh) * 2013-12-03 2014-04-23 镇江圣安医药有限公司 2-（对-（（z-4-氯-1,2-二苯基-1-丁烯基）苯氧基）乙醇的新型衍生物及其应用
GR1009542B (el) 2018-04-25 2019-06-07 Φαρματεν Α.Β.Ε.Ε. Καψουλα μαλακης γελης που περιλαμβανει εναν εκλεκτικο ρυθμιστη οιστρογονικων υποδοχεων
RS64922B1 (sr) 2018-05-11 2023-12-29 Xenon Pharmaceuticals Inc Postupci za povećanje bioraspoloživosti i izloženosti otvaraču naponom kontrolisanih kalijumskih kanala

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9207437D0 (en) * 1992-04-03 1992-05-20 Orion Yhtymae Oy Topical administration of toremifene and its metabolites
GB9418067D0 (en) 1994-09-07 1994-10-26 Orion Yhtymae Oy Triphenylethylenes for the prevention and treatment of osteoporosis
GB9604577D0 (en) 1996-03-04 1996-05-01 Orion Yhtymae Oy Serum cholesterol lowering agent
US6262098B1 (en) * 1998-08-07 2001-07-17 Chiron Corporation Estrogen receptor modulators
US6219674B1 (en) * 1999-11-24 2001-04-17 Classen Immunotherapies, Inc. System for creating and managing proprietary product data
US6245819B1 (en) * 2000-07-21 2001-06-12 Hormos Medical Oy, Ltd. Method for the treatment of vaginal dryness and sexual dysfunction in women during or after the menopause
US6653639B1 (en) * 2000-10-17 2003-11-25 Nikon Corporation Chuck for mounting reticle to a reticle stage
WO2002069254A2 (en) 2001-02-22 2002-09-06 Classen Immunotherapies, Inc. Improved algorithms and methods for products safety
FR2826811B1 (fr) 2001-06-27 2003-11-07 France Telecom Procede d'authentification cryptographique
UA79797C2 (en) 2002-06-06 2007-07-25 Hormos Medical Corp Method for the inhibition of atrophy or for treatment or prevention of atrophy-related symptoms in women
US8236861B2 (en) 2004-02-13 2012-08-07 Hormos Medical Corporation Method for enhancing the bioavailablity of ospemifene
US20050187302A1 (en) * 2004-02-23 2005-08-25 Hormos Medical Corporation Method for treatment or prevention of osteoporosis in individuals with high bone turnover
US8642079B2 (en) * 2004-02-23 2014-02-04 Hormos Medical Corporation Solid formulations of ospemifene
US8758821B2 (en) * 2004-05-04 2014-06-24 Hormos Medical Ltd. Oral formulations of ospemifene
US20060293294A1 (en) 2004-09-03 2006-12-28 Hormos Medical Corporation Method for treatment or prevention of androgen deficiency

Also Published As

Publication number Publication date
CN1925847A (zh) 2007-03-07
RU2006132719A (ru) 2008-03-20
CY1111014T1 (el) 2015-06-11
CA2556089C (en) 2013-04-02
LU92736I2 (fr) 2015-08-10
DK1713458T3 (da) 2008-07-07
US20050182143A1 (en) 2005-08-18
EP1713458B1 (en) 2008-03-05
US20130324614A1 (en) 2013-12-05
US9241915B2 (en) 2016-01-26
US20120270952A1 (en) 2012-10-25
JP5577011B2 (ja) 2014-08-20
DE602005005165T2 (de) 2009-04-30
DK1713458T5 (da) 2008-09-29
US8470890B2 (en) 2013-06-25
US9855224B2 (en) 2018-01-02
US20160101065A1 (en) 2016-04-14
JP2014141533A (ja) 2014-08-07
LTPA2015023I1 (lt) 2015-08-25
MXPA06009274A (es) 2007-04-16
EP1713458A1 (en) 2006-10-25
CY2015027I2 (el) 2016-04-13
US8772353B2 (en) 2014-07-08
JP6023119B2 (ja) 2016-11-09
DE602005005165D1 (de) 2008-04-17
ES2302177T3 (es) 2008-07-01
PT1713458E (pt) 2008-05-07
NO20151603L (no) 2006-11-03
AU2005211958A1 (en) 2005-08-25
ATE387910T1 (de) 2008-03-15
NO339190B1 (no) 2016-11-14
US8236861B2 (en) 2012-08-07
NO337656B1 (no) 2016-05-23
CA2556089A1 (en) 2005-08-25
JP2007522190A (ja) 2007-08-09
WO2005077350A1 (en) 2005-08-25
RU2385716C2 (ru) 2010-04-10
AU2005211958B2 (en) 2010-11-25
HUS1500030I1 (hu) 2015-08-28
LTC1713458I2 (lt) 2017-06-26
NO20063960L (no) 2006-11-03
CY2015027I1 (el) 2016-04-13
PL1713458T3 (pl) 2008-08-29
US20140303259A1 (en) 2014-10-09
BRPI0507661A (pt) 2007-07-17

Similar Documents

Publication Publication Date Title
BE2024C508I2 (zh)
BE2022C549I2 (zh)
BE2024C511I2 (zh)
BE2020C513I2 (zh)
BE2020C517I2 (zh)
BE2019C540I2 (zh)
BE2019C548I2 (zh)
BE2018C045I2 (zh)
BE2017C027I2 (zh)
BE2017C023I2 (zh)
BE2017C002I2 (zh)
BE2016C067I2 (zh)
BE2016C014I2 (zh)
BE2015C041I2 (zh)
BE2015C066I2 (zh)
BE2019C535I2 (zh)
BE2015C065I2 (zh)
BR122015024347A2 (zh)
BRPI0508002A (zh)
BE2016C042I2 (zh)
BE2016C035I2 (zh)
BE2015C033I2 (zh)
JP2005203960A5 (zh)
JP2005292335A5 (zh)
JP2004278523A5 (zh)